CTCs obtained from patients with metastatic breast cancer often show overexpression of stem cell markers, suggesting that metastasis is induced by a subpopulation of CTCs that express a tumour stem-cell marker (CD133 or CD44), have CSCs characteristics and thus can be considered as circulating CSCs (cCSCs) [152,153]. Here, PROM1 is linked to breast carcinoma.